Source: Orange County Business Journal. By Yuika Yoshida.
A recent research study by Helio Genomics, one of Orange County’s better-funded upstart diagnostics firms, suggests it’s found a way to better detect early-stage cancer with a simple blood test.
The Irvine-based cancer diagnostics firm collaborated with the University of California, Irvine for the study, which tested using multiple biomarkers to detect early signs of colon cancer more accurately. The study was published in Genome Medicine.
“Cancer is multidimensional, so you should take a multidimensional approach to detect it.”
Li says the results from the study will help advance the second generation of the company’s first product, HelioLiver, a test that it says detects early-stage liver cancer better than traditional methods.
The company is still going through the approval process for HelioLiver and will be submitting it to the Food and Drug Administration (FDA) this summer, according to Li.
Read the full interview at Orange County Business Journal →
View source version on ocbj.com.